Skip to main content

4 Result(s)

within P. Haentjens Remove this filter English Remove this filter Rheumatology Remove this filter

and

  1. No Access

    Article

    Association between timing of zoledronic acid infusion and hip fracture healing

    Patients in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Recurrent Fracture Trial were assessed for evidence of delayed hip fracture healing. No association was observed...

    C. Colón-Emeric, L. Nordsletten, S. Olson, N. Major… in Osteoporosis International (2011)

  2. No Access

    Article

    Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial

    Treatment with alendronate (Fosamax®) has been shown to significantly reduce the risk of fragility fractures. Cost-effectiveness of treatment was assessed in nine European countries in a Markov model and was g...

    O. Ström, F. Borgström, S. S. Sen, S. Boonen, P. Haentjens… in Osteoporosis International (2007)

  3. No Access

    Article

    The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective

    Risedronate, a bisphosphonate for treatment and prevention of osteoporosis, has been shown in several clinical trials to reduce the risk of fractures in postmenopausal women with osteoporosis. The cost-effecti...

    F. Borgström, Å. Carlsson, H. Sintonen, S. Boonen… in Osteoporosis International (2006)

  4. No Access

    Article

    Costs Induced by Hip Fractures: A Prospective Controlled Study in Belgium

    The economic burden of hip fractures is thought to be important, but the excess medical costs they induce remain largely unknown. We assessed the direct medical costs induced by hip fractures during and after...

    P. Autier, P. Haentjens, J. Bentin, J. M. Baillon… in Osteoporosis International (2000)